Skip to main content

Table 5 Hazard ratios (HR) and 95% CIs for the incidence of chronic obstructive pulmonary disease (COPD), adult-onset asthma, and lung cancer across quintiles of ambient UFP concentrations in Toronto, Canada

From: Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study

Exposure

COPD

Asthma

Lung cancer

HR

95%CI

HR

95%CI

HR

95%CI

Single Pollutant Model

 UFPs (by quintiles) a

  Q1

1.00

  

1.00

  

1.00

  

  Q2

1.05

1.03

1.09

1.04

1.01

1.06

0.97

0.90

1.03

  Q3

1.12

1.08

1.15

1.05

1.02

1.08

1.00

0.92

1.07

  Q4

1.16

1.13

1.19

1.06

1.03

1.09

1.03

0.95

1.10

  Q5

1.12

1.08

1.17

1.06

1.03

1.10

0.96

0.87

1.05

Adjusted for NO 2 and PM 2.5

 UFPs a

  Q1

1.00

  

1.00

  

1.00

  

  Q2

1.04

1.02

1.07

1.03

1.01

1.06

0.95

0.89

1.02

  Q3

1.08

1.05

1.11

1.04

1.01

1.06

0.97

0.90

1.04

  Q4

1.10

1.06

1.13

1.04

1.01

1.07

0.99

0.92

1.07

  Q5

1.03

0.98

1.08

1.03

0.99

1.07

0.91

0.82

1.00

  1. aHazard ratios by quintiles of distributions were estimated in the single-pollutant models stratified by age and sex and adjusted for medical comorbidities and neighborhood-level variables. For COPD, quintiles of UFPs: Q1, ≤ 21,473; Q2, 21,473–24,349; Q3, 24,349–27,813; Q4, 27,813–34,763; Q5, > 34,763 count/cm3. For asthma, quintiles of UFPs: Q1, ≤ 21,459; Q2, 21,459–24,325; Q3, 24,325–27,788; Q4, 27,788–34,726; Q5, > 34,726 count/cm3. For lung cancer, quintiles of UFPs: Q1, ≤ 21,464; Q2, 21,464–24,329; Q3, 24,329–27,793; Q4, 27,793–34,758; Q5, > 34,758 count/cm3